Cardiovascular, mortality, and kidney outcomes with GLP-1 receptor agonists in patients with type 2 diabetes: a systematic review and meta-analysis of randomised trials
It must be stored upright and not within reach of the freezer or cooling elements
Consistency during dose escalation gives your body the best chance to adapt smoothly
These injections, combined with personalized care, help achieve sustainable results
Secondary Research The market for the companies offering GLP-1 agonists is arrived at by secondary data available through paid and unpaid sources, analyzing the product portfolios of the major companies in the ecosystem, their revenue mapping, and rating the companies by their performance and quality
Semaglutide and liraglutide, two prominent GLP-1s, have been particularly effective in reducing cardiovascular events